^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

nivatrotamab (GD2xCD3)

i
Other names: humanized anti-GD2 x anti-CD3 bispecific antibody, GD2xCD3, Hu3F8-BsAb, Humanized 3F8 Bispecific Antibody
Associations
Trials
Company:
Memorial Sloan-Kettering Cancer Center, Y-mAbs Therap
Drug class:
CD3 agonist, GD2 ganglioside inhibitor
Related drugs:
Associations
Trials